Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5901
    -0.0005 (-0.08%)
     
  • NZD/EUR

    0.5526
    -0.0019 (-0.34%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    82.17
    -0.56 (-0.68%)
     
  • GOLD

    2,397.50
    -0.50 (-0.02%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,843.54
    -33.51 (-0.43%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,749.12
    -88.28 (-0.49%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.1600
    -0.0940 (-0.10%)
     

Will Eli Lilly Be a Trillion-Dollar Stock by 2030?

Will Eli Lilly Be a Trillion-Dollar Stock by 2030?

Most investors are comfortable with the idea of businesses like Apple and Microsoft having market caps in excess of $1 trillion. Today, Eli Lilly's market cap is a little north of $410 billion, which puts it among the top handful of big pharma companies. Its trailing 12-month net income is $6.2 billion, and its trailing price-to-earnings ratio is near 69, which is fairly high, but not at bloated tech stock levels.